The follicle reservoir remains intact
Activation of GHS-R1a by ghrelin results in increased activity of phospholipase C beta (PLC) with the consequent production of diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP 3
Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts
A decrease in red blood cell concentration (reflected in the hematocrit) will cause whole blood concentration to fall without a change in pharmacologically active concentrations
In this manuscript, we meticulously traced the origin of each natural product mentioned in all the original research papers and precisely provided their authoritative taxonomic and family information (Supplementary Appendix 15)
For peptide users dosing in the evening (the most common protocol), consuming alcohol earlier in the day still creates an inhibitory environment by the time the peptides are administered